CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ 61,060	$ (174,668)
Adjustments to net income (loss):
Depreciation and amortization	163,031	164,360
Deferred income tax expense (benefit)	4,713	3,721
Impairments and other charges	5,318
Amortization of debt discount and deferred financing costs	2,020	4,984
Losses (gains) on debt buyback	(24,856)	36
Losses (gains) on long-lived assets, net	337	77
Losses (gains) on investments, net	(354)	1
Share-based compensation	3,980	3,879
Foreign currency transaction losses (gains), net	6,454	4,214
Mark-to-market (gain) loss on warrants	(34,565)	71,752
Noncontrolling interest	(11,836)	(9,828)
Other	47	110
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	19,223	(22,775)
Inventory	(16,272)	(5,621)
Other current assets	6,726	(8,039)
Other long-term assets	(5,458)	2,136
Trade accounts payable and accrued liabilities	(47,375)	2,024
Income taxes payable	9,952	682
Other long-term liabilities	11,905	4,309
Net cash provided by (used for) operating activities	154,050	41,354
Cash flows from investing activities:
Purchases of investments	(11,385)	(1,534)
Capital expenditures	(118,734)	(84,258)
Proceeds from sales of assets	1,982	3,671
Other	6	14
Net cash (used for) provided by investing activities	(128,131)	(82,107)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	250,000
Reduction in long-term debt	(232,549)	(86,127)
Debt issuance costs	(7,870)	(3,858)
Proceeds from revolving credit facilities	85,000	40,000
Reduction in revolving credit facilities	(85,000)	(500,000)
Proceeds from issuance of common shares, net of issuance costs		257
Payments for employee taxes on net settlement of equity awards	(7,071)	(4,523)
Dividends to common and preferred shareholders	(194)	(10)
Distributions to noncontrolling interest		(995)
Net cash (used for) provided by financing activities	2,316	(555,256)
Effect of exchange rate changes on cash and cash equivalents	(3,846)	(1,289)
Net increase (decrease) in cash and cash equivalents and restricted cash	24,389	(597,298)
Cash and cash equivalents and restricted cash, beginning of period	737,140	1,273,510
Cash and cash equivalents and restricted cash, end of period	761,529	676,212
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	451,025	991,471
Restricted cash, beginning of period	286,115	282,039
Cash and cash equivalents and restricted cash, beginning of period	737,140	1,273,510
Cash and cash equivalents, end of period	469,438	394,028
Restricted cash, end of period	$ 292,091	$ 282,184
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 761,529	$ 676,212